Our product
Lieberty logo
liberty product
liberty product

Our innovative solution diagnoses and monitors respiratory infections in patients within hospital and nursing home rooms, as well as in hospital at home settings.

Providing real-time, noninvasive bedside detection and monitoring, the system aims to indentify the pathogen involved for both inpatient and outpatient care.

Noninvasive diagnostic &
monitoring of respiratory infections

Identification of the pathogen involved
(coming soon)

Bedside use in hospitals,
nursing homes & home settings

Assessment of antibiotic efficacy
(coming soon)

Oversight of patients to prevent
hospital-acquired respiratory infections

Remote monitoring of patients
hospitalized at home

Unmet medical need.

HOSPITAL SETTINGS (bedside):

> Rapid etiological orientation to deliver the adequate antibiotic therapy

> Supervise the progression and resolution of the infection, ensuring faster discharge

> Timely assessment of antibiotics’ efficacy

> Monitor patients to prevent hospital acquired respiratory infections



HOSPITAL AT HOME SETTINGS (BEDSIDE):

> Diagnostic and prognostic for individuals without access to laboratory tests

> Monitor patients hospitalized at home


Disclaimer: Not CE-marked. Product not available on the market, not for sale.

Read more

Easy to use & self-installation


Patient centric diagnostic solution for respiratory infections





Detect novel gas biomarkers in breath


Identification of the pathogen involved (coming soon)

Noninvasive & continuous monitoring








Early detection through the application of volatolomics













Real-time Data Analytics


AI & cloud-based algorithm














Diagnostic results on hospital platform (coming soon)

Reduce antibiotic consumption

Address Antimicrobial Resistance (AMR)

Reduce cost of care

Enable remote monitoring of patients hospitalized at home